ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

HHS News: Shalala To Form Genetic Testing Advisory Committee

August 14, 1998

AACI Asks Funding Of Cancer Control Directors From Control Budget

February 11, 1983

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Final Money Bill Clear On Permitting New Construction Funding

December 12, 1975

NCI To require Prompt Publication Of Data Affected By Falsification In Future Grants

April 8, 1994

Brinker Again To Lead Komen As CEO

December 11, 2009